Protai For Profit
Protai is driving drug discovery and development by comprehensively mapping the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are developed.
Investors Number:
2.0
Total Funding:
8000000.0
Technology:
Drug development
Employee Number:
11-50
Industry:
PharmTech
Founded Date:
2021-01-01
Headquarters:
Tel Aviv, Tel Aviv, Israel
Last Funding Date:
2022-01-05
Last Funding Type:
Seed
Funding Status:
Seed